Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Sarah McLeod, PhD

Advertisement
Sarah McLeod, PhD | Image Credit: Sarah McLeod LinkedIn

Sarah McLeod, PhD, senior director of Clinical Microbiology at Innoviva Specialty Therapeutics.

Articles by Sarah McLeod, PhD

Sarah McLeod, PhD

Sarah McLeod, PhD, discusses high cure rates with zoliflodacin for uncomplicated gonorrhea

BySarah McLeod, PhD
October 28th 2025

Zoliflodacin study investigator Sarah McLeod, PhD, highlights data presented at IDWeek 2025 in a Q&A.

Advertisement

Latest Updated Articles

  • Sarah McLeod, PhD
    Sarah McLeod, PhD, discusses high cure rates with zoliflodacin for uncomplicated gonorrhea

    October 28th 2025



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

2

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

3

Individualized TRT demonstrates broad symptom improvements beyond sexual function

4

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

5

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us